Literature DB >> 25743340

Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, Brazil.

Claudio Silveira1, Cristina Muccioli2, Gary N Holland3, Jeffrey L Jones4, Fei Yu5, Adam de Paulo2, Rubens Belfort2.   

Abstract

PURPOSE: To investigate ocular involvement (prevalence, incidence, lesion characteristics) following postnatally acquired infection with an "atypical" genotype of Toxoplasma gondii during a well-characterized 2001 outbreak in Santa Isabel do Ivaí, Brazil, attributed to a contaminated municipal reservoir.
DESIGN: Prospective longitudinal cohort study.
METHODS: We performed ophthalmic examinations on 290 of 454 individuals with serologic evidence of T gondii infection during the epidemic (positive IgM antibody tests). Prevalence of ophthalmic findings (intraocular inflammatory reactions [including transient, isolated retinal whitening without clinically apparent retinal necrosis] and necrotizing retinochoroiditis) at initial examination (baseline) and incidence of new findings during 10.5 months of follow-up were calculated. Cumulative risks of ophthalmic events were determined (Kaplan-Meier technique).
RESULTS: Ocular involvement was present in 33 of 288 IgM+ individuals (11.5%) at baseline, including 17 with focal retinal whitening only and 13 with necrotizing retinochoroiditis. Incidence of new ocular involvement was estimated to be 1.73 events per 100 person-months (PM); cumulative risk at 10.5 months was 30.1%. Incident necrotizing retinochoroiditis was more common among those with focal retinal whitening at baseline (6.7/100 PM) than among those with no ocular involvement at baseline (1.11/100 PM; hazard ratio 6.07 [1.94-19.01]; P < .0001).
CONCLUSIONS: Waterborne infection with an atypical genotype of T gondii is associated with substantial risk of ocular involvement. Lesions may continue to develop during the first year after infection. The increased risk of late necrotizing retinochoroiditis associated with isolated focal retinal whitening at presentation suggests the early presence of parasites in the retina, despite initial lack of observable retinal necrosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25743340     DOI: 10.1016/j.ajo.2015.02.017

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Ocular toxoplasmosis: lessons from Brazil.

Authors:  Michael E Grigg; Jitender P Dubey; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2015-06       Impact factor: 5.258

2.  Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants.

Authors:  Despina Contopoulos-Ioannidis; Kelsey M Wheeler; Raymund Ramirez; Cindy Press; Ernest Mui; Ying Zhou; Christine Van Tubbergen; Sheela Prasad; Yvonne Maldonado; Shawn Withers; Kenneth M Boyer; A Gwendolyn Noble; Peter Rabiah; Charles N Swisher; Peter Heydemann; Kristen Wroblewski; Theodore Karrison; Michael E Grigg; Jose G Montoya; Rima McLeod
Journal:  Clin Infect Dis       Date:  2015-09-24       Impact factor: 9.079

Review 3.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

Review 4.  Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned.

Authors:  Jitender P Dubey
Journal:  Parasit Vectors       Date:  2021-05-19       Impact factor: 3.876

5.  Interferon-γ and IL-10 Release Assay for Patients with Ocular Toxoplasmosis.

Authors:  Marcelo Rudzinski; Lais Pardini; Mariana Bernstein; Gastón Moré; Marina Khoury; Silvana Carolina Duarte; Carina Argüelles; Silvia Reina; José Raúl Oubiña
Journal:  Am J Trop Med Hyg       Date:  2020-09-03       Impact factor: 3.707

6.  Risk of Flood-Related Diseases of Eyes, Skin and Gastrointestinal Tract in Taiwan: A Retrospective Cohort Study.

Authors:  Ling-Ya Huang; Yu-Chun Wang; Chin-Ching Wu; Yi-Chun Chen; Yu-Li Huang
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 7.  Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis.

Authors:  Kamal El Bissati; Pauline Levigne; Joseph Lykins; El Bachir Adlaoui; Amina Barkat; Amina Berraho; Majda Laboudi; Bouchra El Mansouri; Azeddine Ibrahimi; Mohamed Rhajaoui; Fred Quinn; Manoradhan Murugesan; Fouad Seghrouchni; Jorge Enrique Gómez-Marín; François Peyron; Rima McLeod
Journal:  Emerg Microbes Infect       Date:  2018-09-27       Impact factor: 7.163

8.  Experimental Toxoplasmosis in Rats Induced Orally with Eleven Strains of Toxoplasma gondii of Seven Genotypes: Tissue Tropism, Tissue Cyst Size, Neural Lesions, Tissue Cyst Rupture without Reactivation, and Ocular Lesions.

Authors:  Jitender P Dubey; Leandra R Ferreira; Mohammad Alsaad; Shiv K Verma; Derron A Alves; Gary N Holland; Glenn A McConkey
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

9.  Symptomatic Acute Toxoplasmosis in Returning Travelers.

Authors:  Andrés F Henao-Martínez; Carlos Franco-Paredes; Alan G Palestine; Jose G Montoya
Journal:  Open Forum Infect Dis       Date:  2018-03-09       Impact factor: 3.835

10.  Evaluation of Serological and Molecular Tests Used for the Identification of Toxoplasma gondii Infection in Patients Treated in an Ophthalmology Clinic of a Public Health Service in São Paulo State, Brazil.

Authors:  Fernando Henrique Antunes Murata; Mariana Previato; Fábio Batista Frederico; Amanda Pires Barbosa; Fabiana Nakashima; Geraldo Magela de Faria; Aparecida Perpétuo Silveira Carvalho; Cristina da Silva Meira Strejevitch; Vera Lucia Pereira-Chioccola; Lilian Castiglioni; Luiz Carlos de Mattos; Rubens Camargo Siqueira; Cinara Cássia Brandão de Mattos
Journal:  Front Cell Infect Microbiol       Date:  2020-02-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.